Forbes May 22, 2024
Sai Balasubramanian, M.D., J.D.

Microsoft is delving even deeper into clinical medicine, evident by the announcement today highlighting the company’s development of a foundation model for pathology in partnership with Providence and the University of Washington. Specifically, the company has leveraged its significant work and progress with generative AI to launch GigaPath, the first whole-slide foundation model for digital pathology that has been pre-trained with real-world data.

The process of transforming a standard microscopy slide of tumor tissue into a high-resolution digital image is widely available. However, the analysis that takes place after digitizing these slides is crucial, as the images often contain millions of key diagnostic and prognostic data points. Tools like GigaPath can significantly transform this process by conducting whole-slide analysis to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Technology
How AI will change the way you use your browser
Humana to Leverage Google Cloud’s GenAI Capabilities to Improve Member Experiences
Eisai adopts Medidata’s AI-driven platform for clinical trials
How Microsoft is turning AI skeptics into AI power users
CMS to reimburse providers for use of AI prostate cancer mapping tool

Share This Article